MedPath

Wuhan Asia Heart Hospital

🇨🇳China
Ownership
-
Established
1999-01-01
Employees
-
Market Cap
-
Website
http://www.wahh.com.cn/

Prognostic Implications of AccuFFRangio-guided PCI in STEMI

Not Applicable
Conditions
Coronary Artery Disease
ST Elevation Myocardial Infarction
Interventions
Other: AccuFFRangio-guided strategy
Other: Angiography-guided strategy
First Posted Date
2022-01-26
Last Posted Date
2022-02-09
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
500
Registration Number
NCT05209503

Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS

Not Applicable
Conditions
Non ST Segment Elevation Acute Coronary Syndrome
Coronary Artery Disease
Percutaneous Coronary Intervention
Interventions
Other: Angiography-guided strategy
Other: AccuFFRangio-guided strategy
First Posted Date
2022-01-21
Last Posted Date
2022-02-09
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
500
Registration Number
NCT05202041

Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

Conditions
Pharmacokinetics and Pharmacodynamics
Atrial Fibrillation
Oral Anticoagulant
First Posted Date
2020-12-24
Last Posted Date
2020-12-24
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
1864
Registration Number
NCT04684056

Detection and Pathogenesis of Novel Protein F

Not yet recruiting
Conditions
Cardiac Disease
Multiple Myeloma
First Posted Date
2020-04-08
Last Posted Date
2020-04-10
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
100
Registration Number
NCT04338386

Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study

Conditions
Pulmonary Arterial Hypertension
First Posted Date
2019-06-06
Last Posted Date
2021-04-14
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
500
Registration Number
NCT03977428
Locations
🇨🇳

Wuhan Asian Heart Hospital, Wuhan, China

Multi-marker Approach for Risk Assessment in PAH

Recruiting
Conditions
Pulmonary Arterial Hypertension
First Posted Date
2019-05-17
Last Posted Date
2021-04-13
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
500
Registration Number
NCT03954405
Locations
🇨🇳

Wuhan Asian Heart Hospital, Wuhan, China

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

Not Applicable
Conditions
Valve Heart Disease
Anticoagulants; Increased
Interventions
First Posted Date
2019-03-21
Last Posted Date
2019-03-26
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
500
Registration Number
NCT03885180
Locations
🇨🇳

Wuhan Asia Heart Hospital, Wuhan, Hubei, China

AI-based Social Software to Manage wARfarin Therapy

Not Applicable
Conditions
Anticoagulant-induced Bleeding
Warfarin Sodium Causing Adverse Effects in Therapeutic Use
Interventions
Behavioral: Human-based social software management model
Behavioral: AI-based social software management model
First Posted Date
2019-03-12
Last Posted Date
2019-03-12
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
500
Registration Number
NCT03870581
Locations
🇨🇳

WAHH, Wuhan, Hubei, China

🇨🇳

Wuhan Asia Heart Hospital, Wuhan, Hubei, China

Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring

Phase 4
Conditions
Stroke
Bleeding
Myocardial Infarction
Venous Thromboembolism
Interventions
First Posted Date
2018-02-09
Last Posted Date
2018-03-14
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
700
Registration Number
NCT03426982
Locations
🇨🇳

Wuhan Asia Heart Hospital, Wuhan, Hubei, China

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

Completed
Conditions
Strokes Thrombotic
Atrial Fibrillation
Interventions
First Posted Date
2017-09-12
Last Posted Date
2017-09-12
Lead Sponsor
Wuhan Asia Heart Hospital
Target Recruit Count
1194
Registration Number
NCT03280641
Locations
🇨🇳

WAHH, Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath